Max Healthcare Institute · NSE: MAXHEALTH · BSE: 543220
Q1 FY25 results · Apr–Jun 2024
Max Healthcare Institute reported revenue from operations of ₹1,542.95 crore (up 20.1% from Q1 FY24) and net profit of ₹236.27 crore (down 1.6% from Q1 FY24) for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,542.95 | 1,284.99 | +20.1% | 1,422.90 | +8.4% |
| Other income | 34.68 | 41.32 | −16.1% | 45.25 | −23.4% |
| Total income | 1,577.63 | 1,326.31 | +18.9% | 1,468.15 | +7.5% |
| Profit before tax | 321.31 | 303.49 | +5.9% | 335.73 | −4.3% |
| Net profit for the period | 236.27 | 240.08 | −1.6% | 251.54 | −6.1% |
| EPS, basic (₹) | 2.43 | 2.47 | −1.6% | 2.59 | −6.1% |
| Net margin (%) | 15.3 | 18.7 | 17.7 |
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 621.39 | 543.63 | +14.3% | 610.11 | +1.8% |
| Other income | 42.87 | 42.73 | +0.3% | 137.77 | −68.9% |
| Total income | 664.26 | 586.36 | +13.3% | 747.88 | −11.2% |
| Profit before tax | 203.16 | 160.98 | +26.2% | 290.62 | −30.1% |
| Net profit for the period | 154.14 | 126.06 | +22.3% | 241.77 | −36.2% |
| EPS, basic (₹) | 1.59 | 1.30 | +22.3% | 2.49 | −36.1% |
| Net margin (%) | 24.8 | 23.2 | 39.6 |
Consolidated
- Filed with BSE
- 02 Aug 2024, 13:30 IST
- Board meeting
- 01 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 02 Aug 2024, 13:30 IST
- Board meeting
- 01 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE